Previously we reported the first example of peptide mimics of a small hydrophobic molecule, a phytohormone gibberellin. The second peptide mimic of gibberellin has been identified from random peptide libraries by its affinity to a type of catalyzing enzyme of gibberellins, which specifically recognizes bioactive gibberellins. These results suggest that even hydrophobic compounds can be mimicked by peptides.
Based on structural diversity, peptides or proteins could behave as mimics of non-proteinaceous compounds, in the sense that they can be recognized by the target molecule of the original ligand, i.e., mimics of epitopes recognized by the antibodies, or mimics of hormones recognized by their receptors. Anti-idiotype antibody (Id-Ab) is a type of proteinaceous mimic. It recognizes the paratope of the first antibody, and therefore has an internal image of the antigen epitope. Id-Abs have been used as probes to screen receptors. The recent identification of a receptor of abscisic acid, a plant hormone, was facilitated by library screening with an Id-Ab of abscisic acid. 1) On the other hand, peptide mimics have been prepared and used mostly as surrogate antigens of carbohydrates for more efficient T-celldependent immunization. 2, 3) Another example of peptide mimics is against double-stranded DNA (dsDNA), which was prepared to study systemic lupus erythematosus, because most lupus patients are positive for antidsDNA antibodies sometime during the course of their disease. 4) Few reports have appeared on peptide mimics of other ligands, with the exception of the water-soluble ligands biotin 5) and deoxynivalenol. 6) In our previous report, two homologous peptides were identified by their binding activities to anti-bioactive gibberellin (GA) antibody. The binding of the peptides to the antibody was specifically inhibited by bioactive GAs, and it was assumed that the peptides are bound to the antibody as mimics of GA structure. 7) This assumption was demonstrated by structural analysis and epitope mapping of one of the peptides by NMR spectroscopy, and docking simulation of the peptide with the antibody, 8) showing that it was the first example of the peptide mimic of a hydrophobic compound. If peptide mimics of hydrophobic molecules are generally available as in this case, they can serve as good immunogens to create antibodies against the original ligands, molecular probes for screening receptors, etc. In this paper, we report another peptide mimic of GA obtained by screening random peptide libraries against VaGA 2-oxidase A1, 9) a GA 2-oxidase of Vigna angularis. GA 2-oxidases catalyze the hydroxylation of the C-2 position of GA molecules, including bioactive GAs such as GA 4 and GA 1 and their precursor GAs. VaGA 2-oxidase A1 recognizes the structure of the bioactive GAs especially well, 9) and therefore can be a good binding partner to obtain peptide mimics of bioactive gibberellins.
We used four different random peptide libraries. One was commercially available Ph. D.-C7C (New England Biolabs), and three were generous gifts from George P. Smith (University of Missouri): the fUSE5/ 6mer library, which displays 6-mer random peptides as fusion with gIII coat protein; the fUSE5/15mer library, which displays 15-mer random peptides as fusion with gIII coat protein; and the f88/15mer library, which displays 15-mer random peptides as fusion with gVIII coat protein. Detailed information on the library construction is available at the web site http://www.biosci. missouri.edu:16080 /smithgp/PhageDisplayWebsite/ PhageDisplayWebsiteIndex.html.
Recombinant VaGA 2-oxidase A1 (VaGA 2-ox) fused to GST was prepared as described previously.
9) The panning procedure was designed to obtain peptides, which are recognized by the GA 2-ox as gibberellin mimics. Phages displaying peptides bound to the 2-oxidase portion other than the GA binding site were y To whom correspondence should be addressed. Fax: +81-3-5841-8025; E-mail: ayoshi@pgr1.ch.a.u-tokyo.ac.jp Abbreviations: GA, gibberellin; GA 2-ox, GA 2-oxidase Biosci. Biotechnol. Biochem., 70 (8), [2004] [2005] [2006] 2006 Note adsorbed by incubation with 2-ox pretreated with GA 4 , and the non-adsorbed phages were incubated with 2-ox with the free GA binding site. The procedure for panning was almost identical to that in Sekimoto et al., 7) except that affinity-purified GA 2-ox-GST fusion was used as a coating antigen at 14 mg ml À1 coat immunotubes. From the above mentioned four peptide libraries, only fUSE5/15mer showed increases in titer by the successive panning procedure: 2:1 Â 10 3 , 6:3 Â 10 3 , and 8:0 Â 10 6 colony forming units (cfu) respectively were obtained after the first, the second, and the third panning when the input phages were set to 2 Â 10 12 cfu for each panning. Out of 24 independent clones after the third panning, 23 showed the identical sequence for the displayed peptide, ADGAHGVYCFADDGYAIFCGAA-GAE----(the italicized residues are in the region of 15-mer random peptides). The peptide contained two cysteine residues, which are thought to form a disulfide cross-link under non-reducing conditions and present a cyclized peptide with an eight-amino acid side chain attached to one of the cysteines (Fig. 1) . Another characteristic of the peptide was the presence of two acidic aspartic acid residues in the middle of the cyclized peptide with relatively hydrophobic residues in the other part of the ring.
The panning procedure was designed to enrich phages displaying peptides, which can bind only VaGA2-ox with a free GA binding site, and therefore are thought to be recognized by the GA binding pocket of the enzyme. This assumption was examined by competitive ELISA analysis, because the enzyme has at least three other possible binding sites for binding with co-factors or co-substrates, 2-oxoglutarate, Fe 2þ , and ascorbic acid. ELISA analysis followed the method described previously 7) except that the ELISA plate wells were coated with affinity-purified GA 2-ox-GST fusion at 14 mg ml À1 , as for panning. Binding of the monoclonal phage to the VaGA2-ox was inhibited only by GA 4 , and not by 2-oxoglutarate, Fe 2þ , or ascorbic acid ( Fig. 2A) . This result strongly suggests that the peptide acts as a GA mimic at least in terms of competitive binding with GA 4 against the same binding site. Next, the specificity of binding against bioactive GA was also confirmed by competitive ELISA using certain GA derivatives (Fig. 2B) . While binding of the phage-displayed peptide was clearly inhibited by GA 4 , the other GA derivatives, GA 4 methyl ester, 3-epi-GA 4 , and GA 35 , which are not as good substrates of GA 2-ox as GA 4 , were much less effective in competing with the peptide. This result further supports the thesis that the peptide is bound at the recognition site of gibberellin substrates. Since it has been shown that the binding of GA tracer, [ 3 H 4 ]-16,17-dihydro-GA 4 , with GA 2-ox was strongly enhanced by Fused to a Capsid Protein, gIIIp. The intramolecular disulfide bond is shown, It is likely to be formed under non-reducing conditions. The 15-amino acid residues in the region of random peptides of the fUSE5/15mer library are shown in bold letters. the presence of 2-oxoglutarate and/or cobalt ion, a competitor of Fe 2þ 9,10) which is likely due to conformational change of the GA-binding site by the binding of these factors, we set up an experiment to see whether the effect of the co-factors would be similarly detected on binding with the peptide. While the binding of [ 3 H 4 ]-16,17-dihydro-GA 4 was enhanced in the presence of either Co 2þ 9) or 2-oxoglutarate, and further promoted by the combination of both these co-factors, 10 ) the binding of the peptide remained constant ( Fig. 2A and C) . This result suggests that the peptide does not mimic dihydro-GA 4 so precisely that the conformational change of the binding site by co-factor binding is similarly reflected on the binding of the peptide and on the binding of the GA 4 tracer.
This study presents the second example of a peptide mimic of a hydrophobic compound, gibberellin. Nonproteinaceous compounds are poorly immunogenic in general, mostly due to T cell-independent immunization. This is why peptide mimics of carbohydrate epitopes have been studied extensively. Antibody preparation against small molecules can be facilitated by using peptide mimics with higher immunogenicity. The peptide mimics also have potentiality as probes for screening receptors of the original ligands. The present result together with our previous results 7) set our expectations that peptide mimics of even small hydrophobic compounds can be prepared by screening random peptide libraries, and can be used for the above-mentioned application studies.
